We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ovarian Cancer Cells "Totally Addicted to Ran", a Key Mobility Protein

News   Jul 10, 2019 | Original story from University of Montreal Hospital Research Centre

 
Ovarian Cancer Cells "Totally Addicted to Ran", a Key Mobility Protein

Ovarian Tumor Microenvironment. Credit: Chris Booth, Kyle Cowdrick, Frank C. Marini. Source: National Cancer Institute/Comprehensive Cancer Center of Wake Forest Univ.

 
 
 

RELATED ARTICLES

Strategies To Better Understand and Combat Brain Cancer

News

Researchers are using artificial intelligence, radiological MRI scans, and genomics to determine relative life expectancy of glioblastoma patients and discover new treatment options.

READ MORE

Clinical Trial Exposes Kidney Cancer's Weakness

News

A team have discovered how an experimental drug being investigated as a treatment for clear cell renal cell carcinoma disables its molecular target.

READ MORE

New Drug Combo Restores Beta Cell Function in Animal Model

News

In a new study carried out in mice, researchers demonstrated for the first time that a targeted combinatorial drug treatment is able to restore beta cell function, achieve beta cell redifferentiation and therefore potentially open new ways for diabetes remission.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE